Clinical Trial

Role of Omega-6 Fatty Acids in Hepatocellular Carcinoma Development.

Study acronym: RO6-HCC
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 4, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational study investigates the association between serum Omega-6 fatty acids and hepatocellular carcinoma development. Adult HCC patients and age - and gender matched healthy controls will be included. Serum Omega-6 levels will be compared between groups to explore potential correlations with disease presence and severity .
Trial Details
NCT Number NCT07265076
Lead Sponsor Sohag University
Conditions Carcinoma, Hpatocellular
Enrollment 100 participants
Start Date 2025-12-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-04